Arcturus Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10628 Science Center Dr Ste 250, San Die...Phone Number
(858) 900-2660Website
www.arcturusrx.comRevenue
$42.4 MillionStock Symbol
ARCTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
3
1
1
About Arcturus Therapeutics
Arcturus Therapeutics, as presented on its official site and in public company information, is a biotechnology company that focuses on the development of innovative messenger RNA-based medicines and vaccines. It leverages proprietary RNA technologies and lipid-mediated delivery systems to advance a diverse pipeline of therapeutic and vaccine candidates, including programs aimed at rare diseases and infectious illnesses. The organization is known for its work in mRNA science and for collaborating globally to bring novel RNA therapies and preventive solutions forward, with a multicultural team driving research, clinical development, and business initiatives from its headquarters in the United States.Explore more
Arcturus Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arcturus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Arcturus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Arcturus Therapeutics recently announced quarterly report
Product Launch: Get notified when Arcturus Therapeutics launches new products
Click to see if Arcturus Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Arcturus Therapeutics
Check out if Arcturus Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Arcturus Therapeutics has new funding data
Check if Arcturus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Arcturus Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Arcturus Therapeutics
Compare insights from companies similar to Arcturus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$97.4M
201-500
Public
$237.2M
1997
CE
Celia EckertSenior Vice President, General Counsel & Corporate Secretary
Company Profile Activity
Activity Insights
Arcturus Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Arcturus Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Arcturus Therapeutics.
Arcturus Therapeutics financials insights
Gather financial insights about Arcturus Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$5.9M
2020
Multiple Rounds
$393M
2023
Other Financing Round
$9M
Arcturus Therapeutics Tech Stack
A closer look at the technologies used by Arcturus Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Award, Events, Healthcare Technology
Arcturus Therapeutics News & Media
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDTCompany ParticipantsNeda Safarzadeh - Vice President and Head of...Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
Wood trimmed stakes in Nvidia, Meta, and Tesla; instead, she added this speculative biotech play.Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsNeda Safarzadeh - Vice President and Head of...Arcturus Therapeutics Spotlights Inhaled mRNA CF Phase 2b Plan, FDA Talks for OTC Program at Summit
Arcturus Therapeutics (NASDAQ:ARCT) used a presentation at Guggenheim’s 2026 Emerging Outlook Biotech Summit to highlight upcoming milestones for its messenger RNA (mRNA) rare disease pipeline, with CEO Joe Payne emphasizing progress in inhaled mRNA for cystic fibrosis (CF) and an intravenously dose
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arcturus Therapeutics
Sign Up For FreeTo access detailed company insights
Arcturus Therapeutics, as presented on its official site and in public company information, is a biotechnology company that focuses on the development of innovative messenger RNA-based medicines and vaccines. It leverages proprietary RNA technologies and lipid-mediated delivery systems to advance a diverse pipeline of therapeutic and vaccine candid... Read More
